In the current study, we found that novel tetrapeptide LCGA-17, with a previously shown affinity for the α2δ subunit of VGCCs, exerts significant anxiolytic- and antidepressant-like effects in animal models of PTSD and depression. Here, ATXN2L is linked to major depressive disorder.